New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer's Disease Presented at the 2025 Alzheimer's Association International Conference

Written By Gerardo Dueñas
Gerardo Dueñas
Previous

Veravas, Inc. joins national accelerator to advance heart and brain health
Next

Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology